A like-for-like comparison for Tendon & Sports Injuries — invasiveness, recovery, evidence level and real cost, side by side, so you can see exactly where each option fits.
Direct answer: For Tendon & Sports Injuries, Surgical repair (for complete tears) is the proven, regulator-backed option (evidence: Strong) but is more invasive (high) with a longer recovery (3–6 months rehabilitation). Stem-cell therapy is less invasive (medium) and cheaper (€4,000–14,000 vs €5,000–15,000), but it is investigational — best considered for earlier-stage disease or when you want to delay or avoid surgery, ideally inside a registered trial.
| Option | Dovezi | Indicative cost | Invasiveness | Recovery |
|---|---|---|---|---|
| Stem-cell therapy | Investigational | €4,000–14,000 | Medium | 2–4 weeks; clinical trials underway |
| Surgical repair (for complete tears) | Strong | €5,000–15,000 | High | 3–6 months rehabilitation |
Acute management follows RICE (rest, ice, compression, elevation) to reduce swelling and pain. NSAIDs (ibuprofen, naproxen) reduce inflammation, though some debate their use in early healing. Immobilisation via brace, sling, or cast protects minor strains and allows initial healing, typically 1–3 weeks depending on severity. Physiotherapy is central: eccentric-loading exercises (lengthening under load) are especially effective for chronic tendinopathy, improving strength and reducing pain. Corticosteroid injections around the tendon (not into it, which risks rupture) may provide short-term relief but should be combined with rehabilitation. Shock-wave therapy (extracorporeal shock-wave therapy, ESWT) shows moderate evidence for some tendon conditions. Complete tears or severe injuries may require surgical repair followed by progressive rehabilitation over 3–6 months.
Stem-cell therapies—particularly bone-marrow-derived mesenchymal stem cells injected into damaged tendons—are being studied for chronic tendinopathy and partial tears. Early trials suggest potential for reducing inflammation and promoting tissue regeneration. These remain investigational and are not yet standard care outside clinical trials. Candidacy typically requires failed conservative treatment and imaging confirmation of pathology. See <a href="../treatments/tendon-sports-injury.html">regenerative approaches for tendon injuries</a> and <a href="../am-i-a-candidate.html">evaluation criteria</a>.
Neither is universally better. Surgical repair (for complete tears) has the strongest evidence and is definitive, but it is invasive with a 3–6 months rehabilitation recovery. Stem-cell therapy is less invasive and cheaper, but unproven — it suits earlier-stage cases or patients avoiding surgery. The right choice depends on your stage, age and goals.
Indicatively €4,000–14,000 for stem-cell therapy versus €5,000–15,000 for Surgical repair (for complete tears) — but cost should never be the deciding factor for an investigational treatment. Always verify GMP certification and approval status first.
No — for Tendon & Sports Injuries it is investigational, not an approved cure. Surgical repair (for complete tears) is the established standard of care. Check whether a registered ClinicalTrials.gov trial is open before paying for private treatment.
Medicină regenerativă certificată GMP în inima UE — de la 3.000–8.000 €, o fracțiune din prețurile din SUA sau Germania. Protocoale personalizate pentru pacienți din peste 50 de țări.
Evaluare medicală gratuită